Jillian C.

Jillian C. has an extensive work experience in the biopharmaceutical and finance industries. Jillian is currently working at Maze Therapeutics as the Head of Treasury & Investor Relations. Jillian'srole focuses on genetically informed therapies for common diseases like chronic kidney disease, utilizing advanced data science methods and a proprietary platform.

Prior to their current position, Jillian worked at Merus N.V. as the Head of Investor Relations & Corporate Communications from September 2018 to March 2021. Jillian also held the role of Head of Investor Relations at WAVE Life Sciences Ltd. from August 2016 to August 2018.

Before their move into the biopharmaceutical industry, Jillian worked as a Consultant at The Trout Group from January 2014 to August 2016. Jillian started their career in finance, working as an Institutional Equity Salesperson at UBS from September 2012 to August 2013, and as part of the Equity Capital Markets team at Bank of America Merrill Lynch from June 2006 to September 2012.

Jillian C. began their education at Westford Academy from 1998 to 2002. Jillian then pursued their degree in International Relations at the University of Pennsylvania from 2002 to 2006, earning a Bachelor of Arts (BA).